IP20-13: ADVANCED-2 (Cohort B): Interim Efficacy and Safety Data in BCG-Unresponsive Participants With High-Grade Non-Muscle Invasive Bladder Cancer
Friday, May 15, 2026 3:30 PM to 5:30 PM · 1 hr. 59 min. (America/New_York)
146A
Abstract
Log in
See all the content and easy-to-use features by logging in or registering!